Ulipristal acetate

Products

Inquiry

Cat. No.: IBDI-437238

Ulipristal acetate (CDB-2914) is an orally active, selective progesterone receptor modulator (SPRM). Ulipristal acetate stimulates the autophagic response selectively in leiomyoma cells. Ulipristal acetate has the potential for benign gynecological conditions treatment, such as uterine myoma.

Size (Solution): 10 mM * 1 mL in DMSO

Size (Solid + Solvent): 10 mM * 1 mL ready for reconstitution

Size (Solid):

Product Details

Target	Progesterone Receptor \| Autophagy
Molecular Weight	475.62
Appearance	Solid
Synonyms	CDB-2914
SMILES	O=C1CCC2=C3[[email protected]@H](C4=CC=C(N(C)C)C=C4)C[[email protected]@]5(C)[[email protected]](CC[[email protected]]5(OC(C)=O)C(C)=O)([H])[[email protected]]3([H])CCC2=C1
Purity	99.89%

Storage & Handling

Shipping	Room temperature in continental US. May vary elsewhere.
Storage	Powder: -20°C/3 years; 4°C/2 years In solvent: -80°C/6 months; -20°C/1 month
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.

! For research use only, not intended for any clinical use.